Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that is hydrolysed to the active diacid trandolaprilat.
Description | Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that is hydrolysed to the active diacid trandolaprilat. |
Molecular Weight | 430.545 |
Formula | C24H34N2O5 |
CAS No. | 87679-37-6 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 100 mg/mL (232.27 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Trandolapril 87679-37-6 代谢 Angiotensin-converting Enzyme (ACE) RU-44570 collagen UUD model inhibit arterial hypertrophy congestive heart failure cellular fibronectin accumulation hypertension CHF RU 44570 spontaneously hypertensive rats RU44570 Inhibitor UUO model orally active nonsulfhydryl myocardial infarction unilateral ureteral obstruction Trandolaprilat inhibitor